{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:28:47Z","timestamp":1740720527322,"version":"3.38.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1007\/bf03192297","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T13:20:01Z","timestamp":1288704001000},"page":"377-381","source":"Crossref","is-referenced-by-count":3,"title":["Comparative bioavailability of two immediate release tablets of cisapride in healthy volunteers"],"prefix":"10.1007","volume":"23","author":[{"given":"M. T.","family":"Maya","sequence":"first","affiliation":[]},{"given":"C. R.","family":"Domingos","sequence":"additional","affiliation":[]},{"given":"M. T.","family":"Guerreiro","sequence":"additional","affiliation":[]},{"given":"A. P.","family":"Filipe","sequence":"additional","affiliation":[]},{"given":"J. A.","family":"Morais","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF03192297_CR1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2165\/00003495-198836060-00002","volume":"36","author":"R. W. McCallum","year":"1988","unstructured":"McCallum R. W., Prakash C., Campoli-Richards D.M., Goa K.L. (1988): Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs, 36, 652\u2013681.","journal-title":"Drugs"},{"key":"BF03192297_CR2","first-page":"23","volume-title":"Progress in the treatment of gastrointestinal motility disorders. The role of cisapride","author":"A. Peer Van","year":"1988","unstructured":"Van Peer A., Verlinden M., Woestenborghs R. et al. (1988): Clinical pharmacokinetics of cisapride. In: Johnson and Lux (Eds). Progress in the treatment of gastrointestinal motility disorders. The role of cisapride. Amsterdam: Excerpta Medica, 23\u201329."},{"key":"BF03192297_CR3","unstructured":"Anon. (1994): Cisapride. An update. Drugs, 47."},{"key":"BF03192297_CR4","first-page":"640","volume":"6","author":"J.A. Barone","year":"1987","unstructured":"Barone J.A., Yih-Chain Huang, Bierman Robert H. et al. (1987): Bioavailability of three oral dosage forms of cisapride, a gastrointestinal stimulant agent. Clin. Pharm., 6, 640\u2013645.","journal-title":"Clin. Pharm."},{"key":"BF03192297_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0090-9556(25)06952-1","volume":"16","author":"W. Meuldermans","year":"1988","unstructured":"Meuldermans W., Van Peer A., Hendrikx J. Lauwers W. et al. (1988): Excretion and biotransformation of cisapride in dogs and humans after oral administration. Drug Metab. Dispos., 16, 403\u2013409.","journal-title":"Drug Metab. Dispos."},{"key":"BF03192297_CR6","unstructured":"Maya M.T., Belchior M., Domingos C., Guerreiro M.T., Morais J.A. (1998 Determination of cisapride in human plasma by high-performance liquid chromatography. Submitted."},{"key":"BF03192297_CR7","unstructured":"Retting Z.R. (1989): Gen\u00e9rica: a software package for statistical analysis of bioavailability studies, v 3.1 Coesfeld."},{"key":"BF03192297_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2307\/2529949","volume":"35","author":"W.J. Westlake","year":"1979","unstructured":"Westlake W.J. (1979): Statistical aspects of comparative bioavailability trials. Biometrics, 35, 273\u2013280.","journal-title":"Biometrics"},{"key":"BF03192297_CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","volume":"15","author":"D.J. Schuirmann","year":"1987","unstructured":"Schuirmann D.J. (1987): A comparison of two one-sided tests procedure and the power approach to assessing the bioequivalence of average bioavailability. J. Pharmacokinet. Biopharm., 15, 657\u2013680.","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"BF03192297_CR10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jps.2600721018","volume":"72","author":"H. Fluehler","year":"1983","unstructured":"Fluehler H., Grieve A.P., Mandallaz D., Mau J., Moser H.A. (1983): Bayesian approach to bioequivalence assessment: an example. J. Pharm. Sci., 72, 1178\u20131181.","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03192297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03192297\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03192297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T13:29:09Z","timestamp":1740662949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03192297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["BF03192297"],"URL":"https:\/\/doi.org\/10.1007\/bf03192297","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}